• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠的VI型黏多糖贮积症:编码芳基硫酸酯酶B的cDNA的分离、该基因的染色体定位及突变鉴定

Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation.

作者信息

Kunieda T, Simonaro C M, Yoshida M, Ikadai H, Levan G, Desnick R J, Schuchman E H

机构信息

Department of Human Genetics, Mount Sinai School of Medicine, New York, New York, USA.

出版信息

Genomics. 1995 Oct 10;29(3):582-7. doi: 10.1006/geno.1995.9962.

DOI:10.1006/geno.1995.9962
PMID:8575749
Abstract

Mucopolysaccharidosis (MPS) type VI, the lysosomal storage disorder caused by the deficiency of arylsulfatase B (ARSB) activity, occurs in humans, cats, and rats. To characterize the molecular lesion(s) causing MPS VI in rats, cDNAs encoding rat ARSB were isolated from a rat liver cDNA library. The nucleotide and deduced amino acid sequences of rat ARSB had approximately 80 and 85% identity with the human ARSB sequences, respectively. The chromosomal location of the rat ARSB gene was determined by PCR analysis of rat-mouse somatic cell hybrid panel. The ARSB gene was assigned to rat chromosome 2, where the locus for the MPS VI phenotype in rats has been localized by linkage analysis. To identify the mutation(s) within the ARSB gene causing MPS VI in rats, the ARSB sequence were amplified from affected animals and completely sequenced. Notably, a homoallelic one-base insertion at nucleotide 507 (507insC) was identified, resulting in a frame shift mutation and premature termination at codon 258. The presence of the insertion completely correlated with the occurrence of the MPS VI phenotype among 66 members of the MPR rat colony. Thus, we conclude that 507insC is the causative mutation in these animals and that the MPS VI rats are an authentic model of human MPS VI.

摘要

VI型黏多糖贮积症(MPS)是一种由芳基硫酸酯酶B(ARSB)活性缺乏引起的溶酶体贮积症,可发生于人类、猫和大鼠。为了确定导致大鼠MPS VI的分子损伤,从大鼠肝脏cDNA文库中分离出编码大鼠ARSB的cDNA。大鼠ARSB的核苷酸序列和推导的氨基酸序列与人类ARSB序列的同源性分别约为80%和85%。通过对大鼠-小鼠体细胞杂交板进行PCR分析,确定了大鼠ARSB基因的染色体定位。ARSB基因被定位到大鼠的2号染色体上,通过连锁分析已将大鼠MPS VI表型的基因座定位在此处。为了鉴定导致大鼠MPS VI的ARSB基因内的突变,从患病动物中扩增出ARSB序列并进行了全序列测定。值得注意的是,在核苷酸507处发现了一个纯合的单碱基插入(507insC),导致移码突变并在第258密码子处提前终止。在MPR大鼠群体的66个成员中,该插入的存在与MPS VI表型的出现完全相关。因此,我们得出结论,507insC是这些动物中的致病突变,并且MPS VI大鼠是人类MPS VI的真实模型。

相似文献

1
Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation.大鼠的VI型黏多糖贮积症:编码芳基硫酸酯酶B的cDNA的分离、该基因的染色体定位及突变鉴定
Genomics. 1995 Oct 10;29(3):582-7. doi: 10.1006/geno.1995.9962.
2
Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1.猫芳基硫酸酯酶B(ARSB):cDNA的分离与表达、与人ARSB的比较以及在猫A1染色体上的基因定位
Genomics. 1992 Oct;14(2):403-11. doi: 10.1016/s0888-7543(05)80233-2.
3
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy.接受酶替代疗法试验的VI型黏多糖贮积症患者的突变分析。
Hum Mutat. 2004 Mar;23(3):229-33. doi: 10.1002/humu.10313.
4
Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.猫I型粘多糖贮积症分子病变的鉴定与特征分析。
Mol Genet Metab. 1999 Jun;67(2):106-12. doi: 10.1006/mgme.1999.2860.
5
Arylsulfatase B activities and glycosaminoglycan levels in retrovirally transduced mucopolysaccharidosis type VI cells. Prospects for gene therapy.逆转录病毒转导的VI型黏多糖贮积症细胞中的芳基硫酸酯酶B活性和糖胺聚糖水平。基因治疗的前景。
J Clin Invest. 1996 Jul 15;98(2):497-502. doi: 10.1172/JCI118817.
6
An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype.一种N-乙酰半乳糖胺-4-硫酸酯酶突变(δG238)导致严重的马罗-拉米表型。
Hum Mutat. 1992;1(5):397-402. doi: 10.1002/humu.1380010509.
7
Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients.台湾黏多糖贮积症VI型患者的基因分析。
Clin Chim Acta. 2008 Aug;394(1-2):89-93. doi: 10.1016/j.cca.2008.04.014. Epub 2008 Apr 27.
8
Mutational analysis of 105 mucopolysaccharidosis type VI patients.105例VI型黏多糖贮积症患者的突变分析
Hum Mutat. 2007 Sep;28(9):897-903. doi: 10.1002/humu.20534.
9
Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy.正在接受酶替代疗法II期试验的VI型黏多糖贮积症患者的突变分析。
Mol Genet Metab. 2007 Feb;90(2):164-70. doi: 10.1016/j.ymgme.2006.10.008. Epub 2006 Dec 11.
10
[Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].[通过新型人类基因的电子克隆和实验验证对NCBI人类基因数据库中出现的模型参考序列的一些错误进行分析、鉴定和校正]
Yi Chuan Xue Bao. 2004 May;31(5):431-43.

引用本文的文献

1
Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches.肌肉骨骼溶酶体贮积症的大鼠模型及其在基因治疗方法临床前评估中的作用。
Mamm Genome. 2025 Mar 18. doi: 10.1007/s00335-025-10121-3.
2
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders.内源性大麻素受体2是溶酶体贮积症的潜在生物标志物和治疗靶点。
J Inherit Metab Dis. 2025 Jan;48(1):e12813. doi: 10.1002/jimd.12813. Epub 2024 Nov 21.
3
Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy.
AAV 介导的基因治疗治疗 IVA 型黏多糖贮积症的骨骼和非骨骼改变。
Nat Commun. 2021 Sep 9;12(1):5343. doi: 10.1038/s41467-021-25697-y.
4
ARSB gene variants causing Mucopolysaccharidosis VI in Miniature Pinscher and Miniature Schnauzer dogs.导致迷你雪纳瑞和迷你笃宾犬黏多糖贮积症 VI 的 ARSB 基因变异。
Anim Genet. 2020 Dec;51(6):982-986. doi: 10.1111/age.13005. Epub 2020 Sep 28.
5
Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes.人类疾病和相关表型的大鼠模型:致病基因的系统清单。
J Biomed Sci. 2020 Aug 2;27(1):84. doi: 10.1186/s12929-020-00673-8.
6
Matching the Diversity of Sulfated Biomolecules: Creation of a Classification Database for Sulfatases Reflecting Their Substrate Specificity.匹配硫酸化生物分子的多样性:创建一个反映硫酸酯酶底物特异性的分类数据库。
PLoS One. 2016 Oct 17;11(10):e0164846. doi: 10.1371/journal.pone.0164846. eCollection 2016.
7
Chondroitin sulfate/dermatan sulfate sulfatases from mammals and bacteria.来自哺乳动物和细菌的硫酸软骨素/硫酸皮肤素硫酸酯酶。
Glycoconj J. 2016 Dec;33(6):841-851. doi: 10.1007/s10719-016-9720-0. Epub 2016 Aug 15.
8
Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.黏多糖贮积症中脊柱疾病的发病机制与治疗
Mol Genet Metab. 2016 Aug;118(4):232-43. doi: 10.1016/j.ymgme.2016.06.002. Epub 2016 Jun 4.
9
Dose responsive effects of subcutaneous pentosan polysulfate injection in mucopolysaccharidosis type VI rats and comparison to oral treatment.注射用聚戊糖多硫酸酯治疗黏多糖贮积症 VI 型大鼠的剂量反应效应及与口服治疗的比较
PLoS One. 2014 Jun 25;9(6):e100882. doi: 10.1371/journal.pone.0100882. eCollection 2014.
10
Sensory-motor behavioral characterization of an animal model of Maroteaux-Lamy syndrome (or Mucopolysaccharidosis VI).马罗-拉米综合征(或黏多糖贮积症VI型)动物模型的感觉运动行为特征
Sci Rep. 2014 Jan 10;4:3644. doi: 10.1038/srep03644.